Limits...
Using a mobile health application to support self-management in chronic obstructive pulmonary disease: a six-month cohort study.

Hardinge M, Rutter H, Velardo C, Shah SA, Williams V, Tarassenko L, Farmer A - BMC Med Inform Decis Mak (2015)

Bottom Line: Patients identified no difficulties in using the mHealth application and used all functions available. 40% of exacerbations had an alert signal during the three days prior to a patient starting medication.Patients were able to use the mHealth application to support self- management, including monitoring of clinical data.Within three months, 95% of symptom reporting sessions were completed in less than 100 s.

View Article: PubMed Central - PubMed

Affiliation: Oxford University Hospitals NHS Trust, UK, Oxford. maxine.hardinge@ouh.nhs.uk.

ABSTRACT

Background: Self-management strategies have the potential to support patients with chronic obstructive pulmonary disease (COPD). Telehealth interventions may have a role in delivering this support along with the opportunity to monitor symptoms and physiological variables. This paper reports findings from a six-month, clinical, cohort study of COPD patients' use of a mobile telehealth based (mHealth) application and how individually determined alerts in oxygen saturation levels, pulse rate and symptoms scores related to patient self-initiated treatment for exacerbations.

Methods: The development of the mHealth intervention involved a patient focus group and multidisciplinary team of researchers, engineers and clinicians. Individual data thresholds to set alerts were determined, and the relationship to exacerbations, defined by the initiation of stand-by medications, was measured. The sample comprised 18 patients (age range of 50-85 years) with varied levels of computer skills.

Results: Patients identified no difficulties in using the mHealth application and used all functions available. 40% of exacerbations had an alert signal during the three days prior to a patient starting medication. Patients were able to use the mHealth application to support self- management, including monitoring of clinical data. Within three months, 95% of symptom reporting sessions were completed in less than 100 s.

Conclusions: Home based, unassisted, daily use of the mHealth platform is feasible and acceptable to people with COPD for reporting daily symptoms and medicine use, and to measure physiological variables such as pulse rate and oxygen saturation. These findings provide evidence for integrating telehealth interventions with clinical care pathways to support self-management in COPD.

No MeSH data available.


Related in: MedlinePlus

Mobile application user interface
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4472616&req=5

Fig4: Mobile application user interface

Mentions: FigureĀ 4 shows the application user interface. The design strategy focussed on usability and readability of the content. A co-design workshop was employed to collect feedback from a group of patients.Fig. 4


Using a mobile health application to support self-management in chronic obstructive pulmonary disease: a six-month cohort study.

Hardinge M, Rutter H, Velardo C, Shah SA, Williams V, Tarassenko L, Farmer A - BMC Med Inform Decis Mak (2015)

Mobile application user interface
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4472616&req=5

Fig4: Mobile application user interface
Mentions: FigureĀ 4 shows the application user interface. The design strategy focussed on usability and readability of the content. A co-design workshop was employed to collect feedback from a group of patients.Fig. 4

Bottom Line: Patients identified no difficulties in using the mHealth application and used all functions available. 40% of exacerbations had an alert signal during the three days prior to a patient starting medication.Patients were able to use the mHealth application to support self- management, including monitoring of clinical data.Within three months, 95% of symptom reporting sessions were completed in less than 100 s.

View Article: PubMed Central - PubMed

Affiliation: Oxford University Hospitals NHS Trust, UK, Oxford. maxine.hardinge@ouh.nhs.uk.

ABSTRACT

Background: Self-management strategies have the potential to support patients with chronic obstructive pulmonary disease (COPD). Telehealth interventions may have a role in delivering this support along with the opportunity to monitor symptoms and physiological variables. This paper reports findings from a six-month, clinical, cohort study of COPD patients' use of a mobile telehealth based (mHealth) application and how individually determined alerts in oxygen saturation levels, pulse rate and symptoms scores related to patient self-initiated treatment for exacerbations.

Methods: The development of the mHealth intervention involved a patient focus group and multidisciplinary team of researchers, engineers and clinicians. Individual data thresholds to set alerts were determined, and the relationship to exacerbations, defined by the initiation of stand-by medications, was measured. The sample comprised 18 patients (age range of 50-85 years) with varied levels of computer skills.

Results: Patients identified no difficulties in using the mHealth application and used all functions available. 40% of exacerbations had an alert signal during the three days prior to a patient starting medication. Patients were able to use the mHealth application to support self- management, including monitoring of clinical data. Within three months, 95% of symptom reporting sessions were completed in less than 100 s.

Conclusions: Home based, unassisted, daily use of the mHealth platform is feasible and acceptable to people with COPD for reporting daily symptoms and medicine use, and to measure physiological variables such as pulse rate and oxygen saturation. These findings provide evidence for integrating telehealth interventions with clinical care pathways to support self-management in COPD.

No MeSH data available.


Related in: MedlinePlus